Suppr超能文献

[利尿剂在充血性心力衰竭患者“利尿剂抵抗”治疗中的应用]

[Diuretics in therapy of "diuretic resistance" by patients with congestive heart failure].

作者信息

Tůma P, Hrdý P

机构信息

Interní klinika IPVZ Krajské nemocnice T Bati, Zlín.

出版信息

Vnitr Lek. 2006 Sep;52(9):782-9.

Abstract

Loop diuretics are integral part of overall therapy of severe congestive heart failure. Approximately 10-20 % of patients with congestive heart failure (NYHA class III-IV) do not respond satisfactorily to diuretic treatment. Despite its frequency, the term "diuretic resistance" remains inadequately defined. In general, failure to decrease the extracellular fluid volume despite liberal use of diuretics is often termed "diuretic resistance". The combination of diuretics, particularly of loop diuretic with thiazide agents, is recommended for prevention as well as treatment of this complication. Effective management is also continuous infusion of loop diuretic. If it is impossible to achieve adequate response by combination of diuretics, increasing of its dosage or/and frequency or continuous infusion, then dialysis methods may be employed (however it is not intended to discuss this option in this article).

摘要

袢利尿剂是重度充血性心力衰竭整体治疗的重要组成部分。约10%-20%的充血性心力衰竭患者(纽约心脏协会III-IV级)对利尿剂治疗反应不佳。尽管其发生率较高,但“利尿剂抵抗”这一术语的定义仍不充分。一般来说,尽管大量使用利尿剂但细胞外液量未能减少,通常被称为“利尿剂抵抗”。推荐联合使用利尿剂,特别是袢利尿剂与噻嗪类药物,用于预防和治疗这种并发症。有效的处理方法还包括持续输注袢利尿剂。如果通过联合使用利尿剂、增加其剂量或/和频率或持续输注无法获得充分反应,那么可以采用透析方法(然而本文不打算讨论此选项)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验